Angiolutions

Angiolutions is a Germany-based startup founded in 2020, operating in the manufacturing industry. The company's slogan "We turn science into medicine" encapsulates its groundbreaking work in abdominal aortic aneurysm (AAA) treatment. With millions of lives at risk due to the lack of early disease interception for abdominal aortic aneurysms, Angiolutions aims to change this narrative. The company is the first to develop a therapeutic device that can effectively prevent disease progression in small abdominal aortic aneurysms. Their innovative approach caught the attention of The European Innovation Council, leading to a grant investment on 23 June 2023. This backing underscores the potential impact of Angiolutions in revolutionizing AAA treatment. With its pioneering technology and strong support from notable investors, Angiolutions is poised to make a significant mark in the medical field, addressing a critical unmet need in healthcare.